Genelux
$2.79
10
+$0.02+0.72% Friday 19:54
Statistics
Day High
2.86
Day Low
2.76
52W High
8.24
52W Low
2.3
Volume
135,700
Avg. Volume
-
Mkt Cap
106.17M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
13MayExpected
Expected EPS
-0.195
Actual EPS
N/A
Financials
-373,362.5%Profit Margin
Unprofitable16,000Revenue
-59.74MNet Income
Analyst Ratings
18Average Price Target
The highest estimate is 20.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 50%
Hold 50%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow GNLX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap189.22B
Merck
MRK
Mkt Cap300.2B
Bristol-Myers Squibb
BMY
Mkt Cap119.69B
Pfizer
PFE
Mkt Cap153.13B
Gilead Sciences
GILD
Mkt Cap172.51B
Novartis
NVS
Mkt Cap297.35B
Roche
RHHBY
Mkt Cap322.3B
Astrazeneca
AZN
Mkt Cap316.3B
Regeneron Pharmaceuticals
REGN
Mkt Cap79.17B
About
Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1 to treat hematologic and solid cancer. The company was incorporated in 2001 and is headquartered in Westlake Village, California.
Show more...
CEO
Mr. Thomas D. Zindrick J.D.
Employees
24
Country
United States
ISIN
US36870H1032
Listings
0 Comments
Share your thoughts
FAQ
What is Genelux stock price today?▼
The current price of GNLX is $2.79 USD — it has increased by +0.72% in the past 24 hours. Watch Genelux stock price performance more closely on the chart.
What is Genelux stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Genelux stocks are traded under the ticker GNLX.
Is Genelux stock price growing?▼
GNLX stock has risen by +9.84% compared to the previous week, the month change is a +7.72% rise, over the last year Genelux has showed a +6.08% increase.
What is Genelux market cap?▼
Today Genelux has the market capitalization of 106.17M
When is the next Genelux earnings date?▼
Genelux is going to release the next earnings report on May 13, 2026.
What were Genelux earnings last quarter?▼
GNLX earnings for the last quarter are -0.24 USD per share, whereas the estimation was -0.22 USD resulting in a -9.92% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Genelux revenue for the last year?▼
Genelux revenue for the last year amounts to 16,000 USD.
What is Genelux net income for the last year?▼
GNLX net income for the last year is -59.74M USD.
How many employees does Genelux have?▼
As of April 18, 2026, the company has 24 employees.
In which sector is Genelux located?▼
Genelux operates in the Health & Wellness sector.
When did Genelux complete a stock split?▼
Genelux has not had any recent stock splits.
Where is Genelux headquartered?▼
Genelux is headquartered in Westlake Village, United States.